Arlon Bennett, APRN
Nurse Practitioner · Florence, MTNPI 1083015242
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $263,284 of the $267,642 with a category attached, or 98.4%. Jubilant Hollisterstier LLC accounts for 98.4% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $101,086, more than ten times the $940 reported in 2021. Among nurse practitioner clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $2249.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jubilant Hollisterstier LLC$263K
- AstraZeneca$2K
- GSK$436
- Blueprint Medicines Corporation$429
- Sanofi$375
- Regeneron Healthcare Solutions, Inc.$274
- plus $1K from 13 others
What the payments were for
- Consulting fees$263,28498%
- Food & beverage$4,2592%
- Education$980%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jubilant Hollisterstier LLC | 6 | $263,403 |
| AstraZeneca | 45 | $1,590 |
| GSK | 14 | $436 |
| Blueprint Medicines Corporation | 9 | $429 |
| Sanofi | 5 | $375 |
| Regeneron Healthcare Solutions, Inc. | 9 | $274 |
| Alk-abello, Inc | 2 | $150 |
| Boehringer Ingelheim | 2 | $148 |
| Genentech USA, Inc. | 8 | $145 |
| Greer Laboratories, Inc. | 3 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $113 |
| Aimmune Therapeutics, Inc. | 1 | $113 |
| Incyte Corporation | 2 | $100 |
| Novartis | 4 | $80 |
| Optinose US, Inc. | 1 | $69 |
| Pfizer | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| USWM, LLC | 1 | $17 |
| Amgen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$267,642 in reported general payments places this provider in the 95th percentile of 357 nurse practitioner providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 17 | $159,455 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 184 | $158,397 |
| Dupixent PenDupilumab | 14 | $51,677 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 41 | $29,844 |
| Spiriva RespimatTiotropium Bromide | 15 | $10,383 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $9,302 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $4,657 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 14 | $2,902 |
| Azelastine Hcl | 106 | $2,349 |
| Ipratropium Bromide | 47 | $1,404 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $1,010 |
| Fluticasone Propionate | 47 | $775 |
| Montelukast Sodium | 83 | $561 |
| Omeprazole | 24 | $311 |
| Famotidine | 26 | $263 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $436 | $167,699204 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,590 | $34,50157 claims |
| Boehringer IngelheimSpiriva Respimat | $148 | $10,38315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 357 nurse practitioner providers in Montana.
Other nurse practitioner in Florence
- Sarah BergMissoula$381K
- Sydney HansonButte$11K
- Jennifer TerrellBillings$7K
- Amanda Abrams-BuerkleyBillings$6K
- Bowen TrystiansonGreat Falls$6K
- Andrea LappBillings$4K
- Amber MolnarGreat Falls$4K
- Jessica BosoGreat Falls$4K
- Whitney McKinleyGreat Falls$3K
- Elizabeth O'ConnorGreat Falls$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.